Literature DB >> 24573789

Recruiting cytotoxic T cells to folate-receptor-positive cancer cells.

Sumith A Kularatne1, Vishal Deshmukh1, Marco Gymnopoulos2, Sandra L Biroc2, Jinming Xia2, Shaila Srinagesh2, Ying Sun2, Ning Zou2, Mark Shimazu2, Jason Pinkstaff2, Semsi Ensari2, Nick Knudsen2, Anthony Manibusan2, Jun Axup1, Chanhyuk Kim1, Vaughn Smider1, Tsotne Javahishvili2, Peter G Schultz1.   

Abstract

Entities:  

Keywords:  T cells; bispecific antibody; cancer; folate receptor; immunotherapy

Mesh：

Substances：

Year:  2013        PMID： 24573789      PMCID： PMC4012751          DOI： 10.1002/anie.201306866

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  22 in total

Review 1.  Bispecific and bifunctional single chain recombinant antibodies.

Authors:  J Kriangkum; B Xu; L P Nagata; R E Fulton; M R Suresh
Journal:  Biomol Eng       Date:  2001-09

2.  Cell surface growth factor receptor molecules as targets for cancer therapy.

Authors:  Oliver M Fischer; Andreas Gschwind; Axel A Ullrich
Journal:  Discov Med       Date:  2004-06       Impact factor: 2.970

3.  Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.

Authors:  Chan Hyuk Kim; Jun Y Axup; Anna Dubrovska; Stephanie A Kazane; Benjamin A Hutchins; Erik D Wold; Vaughn V Smider; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2012-06-06       Impact factor: 15.419

Review 4.  Antibody engineering for therapeutics.

Authors:  Leonard Presta
Journal:  Curr Opin Struct Biol       Date:  2003-08       Impact factor: 6.809

5.  Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

Authors:  Max S Topp; Peter Kufer; Nicola Gökbuget; Mariele Goebeler; Matthias Klinger; Svenja Neumann; Heinz-A Horst; Thorsten Raff; Andreas Viardot; Mathias Schmid; Matthias Stelljes; Markus Schaich; Evelyn Degenhard; Rudolf Köhne-Volland; Monika Brüggemann; Oliver Ottmann; Heike Pfeifer; Thomas Burmeister; Dirk Nagorsen; Margit Schmidt; Ralf Lutterbuese; Carsten Reinhardt; Patrick A Baeuerle; Michael Kneba; Hermann Einsele; Gert Riethmüller; Dieter Hoelzer; Gerhard Zugmaier; Ralf C Bargou
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

Review 6.  The folate receptor: what does it promise in tissue-targeted therapeutics?

Authors:  Marcela D'Alincourt Salazar; Manohar Ratnam
Journal:  Cancer Metastasis Rev       Date:  2007-03       Impact factor: 9.264

Review 7.  Targeted drug delivery via the folate receptor.

Authors:  J Sudimack; R J Lee
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

8.  Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages.

Authors:  Amaya Puig-Kröger; Elena Sierra-Filardi; Angeles Domínguez-Soto; Rafael Samaniego; María Teresa Corcuera; Fernando Gómez-Aguado; Manohar Ratnam; Paloma Sánchez-Mateos; Angel L Corbí
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

9.  Multicenter trial of EC145 in advanced, folate-receptor positive adenocarcinoma of the lung.

Authors:  Martin J Edelman; Wael A Harb; Sridhar E Pal; Ralph V Boccia; Michael J Kraut; Philip Bonomi; Barbara A Conley; John S Rogers; Richard A Messmann; Edward B Garon
Journal:  J Thorac Oncol       Date:  2012-10       Impact factor: 15.609

Review 10.  Blinatumomab: a historical perspective.

Authors:  Dirk Nagorsen; Peter Kufer; Patrick A Baeuerle; Ralf Bargou
Journal:  Pharmacol Ther       Date:  2012-08-24       Impact factor: 12.310
View more
  12 in total

Review 1.  Chemically programmed antibodies.

Authors:  Christoph Rader
Journal:  Trends Biotechnol       Date:  2014-03-11       Impact factor: 19.536

Review 2.  Therapeutic applications of an expanded genetic code.

Authors:  Sophie B Sun; Peter G Schultz; Chan Hyuk Kim
Journal:  Chembiochem       Date:  2014-07-18       Impact factor: 3.164

3.  Template-directed covalent conjugation of DNA to native antibodies, transferrin and other metal-binding proteins.

Authors:  Christian B Rosen; Anne L B Kodal; Jesper S Nielsen; David H Schaffert; Carsten Scavenius; Anders H Okholm; Niels V Voigt; Jan J Enghild; Jørgen Kjems; Thomas Tørring; Kurt V Gothelf
Journal:  Nat Chem       Date:  2014-07-20       Impact factor: 24.427

Review 4.  At the Interface of Chemical and Biological Synthesis: An Expanded Genetic Code.

Authors:  Han Xiao; Peter G Schultz
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

Review 5.  Novel immunotherapies for hematologic malignancies.

Authors:  Michelle H Nelson; Chrystal M Paulos
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

6.  Chemically Programmed Bispecific Antibodies in Diabody Format.

Authors:  Even Walseng; Christopher G Nelson; Junpeng Qi; Alex R Nanna; William R Roush; Rajib K Goswami; Subhash C Sinha; Terrence R Burke; Christoph Rader
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

Review 7.  Playing with the Molecules of Life.

Authors:  Douglas D Young; Peter G Schultz
Journal:  ACS Chem Biol       Date:  2018-03-02       Impact factor: 5.100

Review 8.  Expanding and reprogramming the genetic code.

Authors:  Jason W Chin
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

9.  Antibody Therapeutics in Oncology.

Authors:  Erik D Wold; Vaughn V Smider; Brunhilde H Felding
Journal:  Immunotherapy (Los Angel)       Date:  2016-02-01

Review 10.  Therapeutic applications of genetic code expansion.

Authors:  Yujia Huang; Tao Liu
Journal:  Synth Syst Biotechnol       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.